Message #1 From:
Stock News Bot Date: December 7, 2005 06:43:00 AM
NTRZ News Dutton Associates Announces Investment Opinion: NutraCea Raised to Strong Buy Rating by Dutton Associates
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dec. 7, 2005--Dutton Associates updates its coverage of NutraCea (OTCBB:NTRZ) raising its rating to Strong Buy and maintaining its $1.80 price target. The 7-page report by Dutton senior analyst Gerald F. LaKarnafeaux, CFA, is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading financial portals.
With this report we are upgrading our rating of NutraCea common stock from a Strong Speculative Buy to a Strong Buy. In our April 28, 2005, Update Report we stated there were speculative elements that warranted relative caution. Subsequently, the Company has progressed to the point where we believe the speculative risk has been considerably reduced. The progress includes the following: 1) Merger with RiceX completed, 2) Several promising marketing initiatives that should cause a substantial increase in domestic sales in 2006, and 3) There has been progress in the development of international food programs that will provide profitable sales in 2006. NutraCea is selling at a sizeable discount from major and specialty food processors in spite of its favorable prospects for sales and earnings growth in 2006 as discussed in our report. We are estimating 2006 revenues of $34.4 million with EPS of $.12.
About Dutton Associates
Dutton Associates is one of the largest independent investment research firms in the U.S. Its 27 senior analysts are primarily CFAs and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 90 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.
The cost of enrollment in our one-year continuing research program is US $33,000 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. Dutton Associates received $33,000 from shareholders -- Carl Kruse and Craig Horn for 4 Research Reports with coverage commencing on 1/28/2005. We do not accept payment of our fees in company stock. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.
